The Vasopressin Biomarker Copeptin Is Linked to Systemic Inflammation and Refines Prognostication in Decompensated CirrhosisLukas Hartl, Thomas Reiberger, Marlene Hintersteininger et al.|Clinical Gastroenterology and Hepatology|2025Cited by 6
Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis modelsThomas Sorz, Thomas Reiberger, Katharina Regnat et al.|Scientific Reports|2025Cited by 4
Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With CirrhosisNina Dominik, Benedikt Hofer, Benedikt Simbrunner et al.|Liver International|2025Cited by 4
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and DeathMathias Jachs, Mattias Mandorfer, Tânia Carvalho et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 3
SAT-489 Monitoring hepatic function at 90 days of abstinence predicts recompensation and reduced liver-related mortality in patients with decompensated alcohol-related cirrhosisJan Embacher, Benedikt Hofer, Lukas Parandian et al.|Journal of Hepatology|2025Cited by 1